Max has been involved with the Strategy since its inception in 2006 having managed the integration and development of the Strategy within the Firm’s macro fund. In addition to his duties as Chair of the Systematic Risk Committee, Max is a member of the Firm’s Macro Risk Committee. He is also a member of the Firm’s Board as well as a partner in the Firm and is registered as a Senior Manager with the UK Financial Conduct Authority. Max read Pharmacology at Kings College London and Imperial College London before graduating in 1997, going on to work at JPMorgan as an interest-rate derivatives analyst. Max joined the Firm in 2004.